3Depierre A, Chastang C, Quoix E, et al. Vinonelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer:a randomized trial[J]. Ann Oncol, 1994,5 (1) : 37-42.
2Beyer DC, Puente F, Rogers KL, et al. Prostate brachy therapy: comparison of dose distribution with different 125Ⅰ source designs[J]. Radiology, 2001, 221 (3) :623.
3Ankem MK, DeCarvalho VS, Harangozo AM, et al. Implications of radioactive seed migration to the lungs after prostate brachytherapy[J]. Urology, 2002,59 (4): 555.
4Raben A, Mychalczak B. Brachy-therapy for non-small cell lung cancer and selected neoplasms of the chest[J]. Chest, 1997,112: 276s.
5Chen A, Galloway M, Landreneau R, et al. Intraopera tive 125Ⅰbrachytherapy for high-risk stage Ⅰ non-small cell lung carcinoma[J]. Int J Radiat Oncol Biol Phys,2000 ,6(4): 1083.
2Lee W, Dal y BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of 1-125 brachythcrapy seeds [ J ]. Ann Thorac Surg,2003,75 ( 1 ) :237 - 243.
3d'Amato TA, Galloway M, Szydlowaki G, et al. lntraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer[ J]. Chest,1998,114(4) :1112 - 1115.
